Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

Endoscopic-assisted surgery leads to higher patient satisfaction in breast reconstruction.

Bariatric surgery improves health but often causes hair loss and vitamin deficiency.

Lifestyle changes can improve skin health and reduce disease symptoms.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Higher air pollution increases the risk of alopecia areata.

Caregiver burden and patient health issues significantly affect emotional distress in both COPD patients and their caregivers.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The oral contraceptive improved hair and skin quality in women.

Sertoli cell transplants can reduce inflammation and improve sperm quality.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Hair follicles can be used to study gene expression and understand conditions like COPD.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Baricitinib is effective and safe for treating severe alopecia areata.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Low-glycemic index diets are beneficial for weight loss and satiety, but more research is needed on long-term effects and individualized approaches are recommended.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Gene therapy in mice increased lifespan and improved health without causing cancer.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.